Intertek’s Ashleigh Wake On Opportunities And Challenges With Biosimilars – An Interview With PharmAsia News
This article was originally published in PharmAsia News
Recently Indian biosimilars have made headlines with Biocon Ltd. and Mylan Inc. announcing launches of trastuzumab biosimilars. For its part, Roche has been critical of the approval process in India, questioning the quality of biosimilars. PharmAsia News spoke to a key observer of the biosimilar scene for insight and perspective on the broader issues.